Dr. Leen Vandecasteele
ActiveDr. Leen Vandecasteele has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €87k and a net result of €67k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 50% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
83
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency88▼-12
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 2.73 against 6.91 in 2024; short-term debt: 34.6% and cash: 5.8% of total assets), and 37.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
62.8%
Return on assets
48.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
10 d early
2024
23 d early
2023
20 d early
2022
34 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€87k▼ 48.8%
2024 · €170k
2022: €12k
2023: €85k
2024: €170k
2022 → 2025
Total assets
€138k▼ 32.6%
2024 · €205k
2022: €30k
2023: €119k
2024: €205k
2022 → 2025
Net result
€67k▼ 20.9%
2024 · €85k
2022: €8k
2023: €72k
2024: €85k
2022 → 2025
Working capital
€83k▼ 49.7%
2024 · €165k
2022: €14k
2023: €78k
2024: €165k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€12k-€85k▲ 596%€170k▲ 100%€87k▼ 48.8%
Operating result€10k-€89k▲ 813%€103k▲ 15.3%€81k▼ 21.9%
Net result€8k-€72k▲ 788%€85k▲ 17.3%€67k▼ 20.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 22% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €138k
Fixed assets
€7k▼ 39.6%
Current assets
€131k▼ 32.2%
Equity and liabilities €138k
Equity
€87k▼ 48.8%
Debt
€51k▲ 45.2%
The debt ratio rises from 17.3% to 37.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€85k▼
2024 · €109k
Cash flow
€72k▼
2024 · €90k
Solvency
62.8%▼
2024 · 82.7%
Current ratio
2.73▼
2024 · 6.91
Quick ratio
2.73▼
2024 · 6.91
Debt / equity
0.59▲
2024 · 0.21
ROE
77.5%▲
2024 · 50.1%
ROA
48.7%▲
2024 · 41.5%
Interest coverage
545.87▼
2024 · 2497.73
Debt
€51k▲
2024 · €35k
Debt ≤ 1 year
€48k▲
2024 · €28k
Debt > 1 year
€4k▼
2024 · €8k
Income taxes
€17k▼
2024 · €22k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€205k€138k▼
Fixed assets21/28€12k€7k▼
Intangible fixed assets21€3k€2k▼
Tangible fixed assets22/27€9k€5k▼
Plant, machinery and equipment23€483€0▼
Furniture and vehicles24€9k€5k▼
Current assets29/58€193k€131k▼
Amounts receivable within one year40/41€43k€52k▲
Other amounts receivable41€43k€52k▲
Current investments50/53-€68k
Cash at bank and in hand54/58€146k€8k▼
Deferred charges and accrued income490/1€4k€3k▼
Equity and liabilities
Total equity and liabilities10/49€205k€138k▼
Equity10/15€170k€87k▼
Contributions10/11€4k€4k=
Reserves13€166k€83k▼
Distributable reserves133€166k€83k▼
Profit (loss) carried forward14-€0
Amounts payable17/49€35k€51k▲
Amounts payable after more than one year17€8k€4k▼
Financial debts170/4€8k€4k▼
Amounts payable within one year42/48€28k€48k▲
Current portion of amounts payable after more than one year42€4k€4k=
Trade debts44€958€1k▲
Suppliers440/4€958€1k▲
Taxes, remuneration and social security45€22k€24k▲
Taxes450/3€22k€24k▲
Other amounts payable47/48€769€19k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k▼
Other operating charges640/8€419€585▲
Gross operating margin9900€109k€86k▼
Operating profit (loss)9901€103k€81k▼
Financial income75/76B€4k€4k▼
Recurring financial income75€4k€4k▼
Financial charges65/66B€44€157▲
Recurring financial charges65€44€157▲
Profit (loss) for the period before taxes9903€107k€84k▼
Income taxes67/77€22k€17k▼
Profit (loss) for the period9904€85k€67k▼
Profit (loss) for the period to be appropriated9905€85k€67k▼
Appropriation of the result
Profit (loss) to be appropriated9906€85k€67k▼
Transfer from equity791/2-€150k
Transfer to equity691/2€85k€67k▼
To other reserves6921€85k€67k▼
Profit to be distributed694/7-€150k
Return on contributions (dividend)694-€150k
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €85k ▲17.3%
Operating result €103k, net result €85k, both a record.
31-12
Financial
Equity above €150kEq €170k ▲100%
3 profitable years in a row build equity to €170k.
11-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
27-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoogstraten · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heuvelstraat 16a2320 HoogstratenGround area
3,618 m²
Building footprint
418 m²
Volume, LiDAR
2,132 m³
2 parcels, Flanders · tallest building 8.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Leen Vandecaste
since 20222.336.242.921
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13014F0059/00A000 | Flanders | 1,989 m² | 1 · 232 m² | 6.8 m · 2 fl. |
| 13014F0060/00W000 | Flanders | 1,629 m² | 1 · 185 m² | 8.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. E. DESMEDT
BE 0448.961.332
Mortsel · Eq €87k
Dr. Van de Vel Ingrid
BE 0861.300.612
Antwerpen · Eq €87k
DOCTEUR NONET Margaux
BE 0778.547.437
Profondeville · Eq €87k
Dr. Aline Nguyen
BE 1008.457.035
Antwerpen · Eq €87k
MEDILLIE SRL
BE 0797.843.212
Philippeville · Eq €87k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,168 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-10-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.